← Back to Influence Map
Entity DossierOrganization
Biotechnology Innovation Organization (BIO)
DC · US
Tracked direct receipts exceed tracked direct giving by
$10,000
Trade association representing biotech companies. Lobbies to protect biologics data exclusivity and patent protections for biologic drugs.
pharmaceuticals
Tracked direct giving
$0
Tracked receipts
$10,000
Connections
5
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Donations Received and Outside Spending
Largest 50 records. Badged rows are independent expenditures other groups paid to vendors for or against this entity. That money did not reach its committee.
| Donor | Amount | Date | Cycle |
|---|---|---|---|
| SCALISE FOR CONGRESS | $5,000 | Mar 27, 2023 | 2024 |
| Merck & Co. Inc. PAC | $5,000 | Sep 15, 2024 | 2024 |
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Commented on | Department of Energy | Public comment on DOE-HQ-2010-0002: National Environmental Policy Act Implementing Procedures | Source |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2024-0189: Medicare Program: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney I | Source |
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $80,000 | Source |
| Retained | ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | Hired ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) to lobby on NIH March-In Rights | Source |
| Instrument of | Pharmaceutical industry | BIO represents biotech companies in patent and regulatory policy | Editorial |